High-sensitivity cTnI is a predictor of mortality and vascular events in patients after ischemic stroke, and elevated high-sensitivity cTnI increases the risk of adverse cardiovascular and cerebrovascular events [29]. The gene discussed is TNNI3; the disease is ischemic stroke.